The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions

References

• Man K, Kutyavin VI, Chawla A. Tissue immunometabolism: development, physiology, and pathobiology. Cell Metab. 2017;25(1):11–26. doi:10.1016/j.cmet.2016.08.016
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-: direct role in obesity-linked insulin resistance. Sci NY Washinton. 1993;259:87. doi:10.1126/science.7678183
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–1808. doi:10.1172/JCI200319246
   PubMed Web of Science ®Google Scholar
• Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflammation. 2013;2013:1–12. doi:10.1155/2013/139239
   Google Scholar
• Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. doi:10.1038/nri2921
   PubMed Web of Science ®Google Scholar
• Boa B, Yudkin J, Hinsbergh V, Bouskela E, Eringa E. Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function. Br J Pharmacol. 2017;174(20):3466–3481. doi:10.1111/bph.v174.20
   PubMed Web of Science ®Google Scholar
• Wensveen FM, Valentić S, Šestan M, Turk Wensveen T, Polić B. The “Big Bang” in obese fat: events initiating obesity‐induced adipose tissue inflammation. Eur J Immunol. 2015;45(9):2446–2456. doi:10.1002/eji.201545502
   PubMed Web of Science ®Google Scholar
• León-Pedroza JI, González-Tapia LA, del Olmo-Gil E, Castellanos-Rodríguez D, Escobedo G, González-Chávez A. Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice. Cirugía y Cirujanos. 2015;83(6):543–551. doi:10.1016/j.circen.2015.11.008
   PubMed Web of Science ®Google Scholar
• Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293(4):E1118–E1128. doi:10.1152/ajpendo.00435.2007
   PubMed Web of Science ®Google Scholar
• Kitamura H, Kimura S, Shimamoto Y, et al. Ubiquitin-specific protease 2–69 in macrophages potentially modulates metainflammation. FASEB J. 2013;27(12):4940–4953. doi:10.1096/fsb2.v27.12
   PubMed Web of Science ®Google Scholar
• Timmerman KL, Flynn MG, Coen PM, Markofski MM, Pence BD. Exercise training-induced lowering of inflammatory (CD14+ CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol. 2008;84(5):1271–1278. doi:10.1189/jlb.0408244
   PubMed Web of Science ®Google Scholar
• Markofski MM, Flynn MG, Carrillo AE, Armstrong CL, Campbell WW, Sedlock DA. Resistance exercise training-induced decrease in circulating inflammatory CD14+ CD16+ monocyte percentage without weight loss in older adults. Eur J Appl Physiol. 2014;114(8):1737–1748. doi:10.1007/s00421-014-2902-1
   PubMed Web of Science ®Google Scholar
• Rodriguez-Miguelez P, Fernandez-Gonzalo R, Almar M, et al. Role of toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects. Age. 2014;36(6):9734. doi:10.1007/s11357-014-9734-0
   PubMedGoogle Scholar
• Bonfante ILP, Chacon-Mikahil MPT, Brunelli DT, et al. Combined training, FNDC5/irisin levels and metabolic markers in obese men: a randomised controlled trial. Eur J Sport Sci. 2017;17(5):629–637. doi:10.1080/17461391.2017.1296025
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Pocheć E, Zarawski M. Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci. 2017;18(4):701. doi:10.3390/ijms18040701
   PubMed Web of Science ®Google Scholar
• Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro‐and anti‐inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 1999;515(1):287–291. doi:10.1111/j.1469-7793.1999.287ad.x
   PubMedGoogle Scholar
• Balducci S, Zanuso S, Nicolucci A, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20(8):608–617. doi:10.1016/j.numecd.2009.04.015
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–185. doi:10.1038/nature21363
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2009;28:445–489. doi:10.1146/annurev-immunol-030409-101212
   Web of Science ®Google Scholar
• Wu D, Molofsky AB, Liang H-E, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011;332(6026):243–247. doi:10.1126/science.1201475
   PubMed Web of Science ®Google Scholar
• Molofsky AB, Nussbaum JC, Liang H-E, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med. 2013;210(3):535–549. doi:10.1084/jem.20121964
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184. doi:10.1172/JCI29881
   PubMed Web of Science ®Google Scholar
• Ilavská S, Horváthová M, Szabová M, et al. Association between the human immune response and body mass index. Hum Immunol. 2012;73(5):480–485. doi:10.1016/j.humimm.2012.02.023
   PubMed Web of Science ®Google Scholar
• Patsouris D, Li -P-P, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008;8(4):301–309. doi:10.1016/j.cmet.2008.08.015
   PubMed Web of Science ®Google Scholar
• Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity. 2015;42(6):1005–1019. doi:10.1016/j.immuni.2015.06.006
   PubMed Web of Science ®Google Scholar
• Hashiguchi M, Kashiwakura Y, Kojima H, Kobayashi A, Kanno Y, Kobata T. IL‐33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells. Eur J Immunol. 2015;45(3):876–885. doi:10.1002/eji.201444969
   PubMedGoogle Scholar
• Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013;17(6):851–859. doi:10.1016/j.cmet.2013.05.008
   PubMed Web of Science ®Google Scholar
• Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15(8):930–939. doi:10.1038/nm.2002
   PubMed Web of Science ®Google Scholar
• Vasanthakumar A, Moro K, Xin A, et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol. 2015;16(3):276–285. doi:10.1038/ni.3085
   PubMed Web of Science ®Google Scholar
• Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15(8):921–929. doi:10.1038/nm.2001
   PubMed Web of Science ®Google Scholar
• Barnes MA, Carson MJ, Nair MG. Non-traditional cytokines: how catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine. 2015;72(2):210–219. doi:10.1016/j.cyto.2015.01.008
   PubMed Web of Science ®Google Scholar
• Qiu Y, Shan B, Yang L, Liu Y. Adipose tissue macrophage in immune regulation of metabolism. Sci China Life Sci. 2016;59(12)1–9.
   PubMedGoogle Scholar
• Bai Y, Sun Q. Macrophage recruitment in obese adipose tissue. Obesity Rev. 2015;16(2):127–136. doi:10.1111/obr.2015.16.issue-2
   PubMed Web of Science ®Google Scholar
• Thomas D, Apovian C. Macrophage functions in lean and obese adipose tissue. Metabolism. 2017;72:120–143. doi:10.1016/j.metabol.2017.04.005
   PubMed Web of Science ®Google Scholar
• Boutens L, Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia. 2016;59(5):879–894. doi:10.1007/s00125-016-3904-9
   PubMed Web of Science ®Google Scholar
• Bigornia S, Farb M, Mott M, et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes. 2012;2(3):e30. doi:10.1038/nutd.2012.3
   PubMedGoogle Scholar
• Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Fron immunol. 2014;5. doi:10.3389/fimmu.2014.00514
   PubMedGoogle Scholar
• Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1–m2 polarization balance. Front Immunol. 2014;5. doi:10.3389/fimmu.2014.00614
   Google Scholar
• Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783–787. doi:10.1038/nature06902
   PubMed Web of Science ®Google Scholar
• Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest. 2010;120(10):3466–3479. doi:10.1172/JCI42845
   PubMed Web of Science ®Google Scholar
• Shapiro H, Pecht T, Shaco-Levy R, et al. Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab. 2013;98(3):1173–1181. doi:10.1210/jc.2012-2745
   PubMedGoogle Scholar
• Castoldi A, de Souza CN, Câmara NOS, Moraes-Vieira PM. The macrophage switch in obesity development. Front Immunol. 2016;6:637.
   PubMed Web of Science ®Google Scholar
• Kamei N, Tobe K, Suzuki R, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006;281(36):26602–26614. doi:10.1074/jbc.M601284200
   PubMed Web of Science ®Google Scholar
• Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175(6):3463–3468. doi:10.4049/jimmunol.175.6.3463
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta Mol Cell Res. 2011;1813(5):878–888. doi:10.1016/j.bbamcr.2011.01.034
   PubMed Web of Science ®Google Scholar
• Kraakman MJ, Kammoun HL, Allen TL, et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 2015;21(3):403–416. doi:10.1016/j.cmet.2015.02.006
   PubMed Web of Science ®Google Scholar
• Xueyao Y, Saifei Z, Dan Y, et al. Circulating fractalkine levels predict the development of the metabolic syndrome. Int J Endocrinol. 2014;2014.
   PubMed Web of Science ®Google Scholar
• Shah R, Hinkle CC, Ferguson JF, et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes. 2011;60(5):1512–1518. doi:10.2337/db10-0956
   PubMed Web of Science ®Google Scholar
• Polyák Á, Ferenczi S, Dénes Á, et al. The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity. Brain Behav Immun. 2014;38:25–35. doi:10.1016/j.bbi.2014.01.010
   PubMedGoogle Scholar
• Dominguez H, Storgaard H, Rask-Madsen C, et al. Metabolic and vascular effects of tumor necrosis factor-α blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res. 2005;42(6):517–525. doi:10.1159/000088261
   PubMed Web of Science ®Google Scholar
• Serino M, Menghini R, Fiorentino L, et al. Mice heterozygous for tumor necrosis factor-α converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes. 2007;56(10):2541–2546. doi:10.2337/db07-0360
   PubMed Web of Science ®Google Scholar
• Xu X, Grijalva A, Skowronski A, van Eijk M, Serlie MJ, Ferrante AW. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 2013;18(6):816–830. doi:10.1016/j.cmet.2013.11.001
   PubMed Web of Science ®Google Scholar
• Mills C. M1 and M2 macrophages: oracles of health and disease. Crit Reviews™ in Immunol. 2012;32(6).
   PubMedGoogle Scholar
• Hill DA, Lim H-W, Kim YH, et al. Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc National Acad Sci. 2018;115(22):E5096–E5105. doi:10.1073/pnas.1802611115
   PubMed Web of Science ®Google Scholar
• Peterson KR, Cottam MA, Kennedy AJ, Hasty AH. Macrophage-Targeted therapeutics for metabolic disease. Trends Pharmacol Sci. 2018;39(6):536–546. doi:10.1016/j.tips.2018.03.001
   PubMed Web of Science ®Google Scholar
• Porta C, Riboldi E, Ippolito A, Sica A Molecular and epigenetic basis of macrophage polarized activation. Paper Presented at: SEMINARS in Immunology; 2015. doi:10.1016/j.smim.2015.10.003
   Google Scholar
• Han MS, Jung DY, Morel C, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science. 2013;339(6116):218–222. doi:10.1126/science.1227568
   PubMed Web of Science ®Google Scholar
• Gao Z, Hwang D, Bataille F, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem. 2002;277(50):48115–48121. doi:10.1074/jbc.M209459200
   PubMed Web of Science ®Google Scholar
• Banks AS, McAllister FE, Camporez JPG, et al. An ERK/Cdk5 axis controls the diabetogenic actions of PPAR [ggr]. Nature. 2015;517(7534):391–395. doi:10.1038/nature13887
   PubMed Web of Science ®Google Scholar
• Carlson CJ, Koterski S, Sciotti RJ, Poccard GB, Rondinone CM. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential Role of p38 in the downregulation of GLUT4 expression. Diabetes. 2003;52(3):634–641. doi:10.2337/diabetes.52.3.634
   PubMedGoogle Scholar
• Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes. 2008;57(12):3239–3246. doi:10.2337/db08-0872
   PubMed Web of Science ®Google Scholar
• Jeffery E, Church CD, Holtrup B, Colman L, Rodeheffer MS. Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat Cell Biol. 2015;17(4):376–385. doi:10.1038/ncb3122
   PubMed Web of Science ®Google Scholar
• Talukdar S, Bandyopadhyay G, Li D, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012;18(9):1407–1412. doi:10.1038/nm.2885
   PubMed Web of Science ®Google Scholar
• Wensveen FM, Jelenčić V, Valentić S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16(4):376–385. doi:10.1038/ni.3120
   PubMed Web of Science ®Google Scholar
• Amano SU, Cohen JL, Vangala P, et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2014;19(1):162–171. doi:10.1016/j.cmet.2013.11.017
   PubMed Web of Science ®Google Scholar
• Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116(6):1494–1505. doi:10.1172/JCI26498
   PubMed Web of Science ®Google Scholar
• Pecht T, Gutman‐Tirosh A, Bashan N, Rudich A. Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans. Obesity Rev. 2014;15(4):322–337. doi:10.1111/obr.12133
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang L, Yu C, Yang X-F, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomarker Res. 2014;2(1):1. doi:10.1186/2050-7771-2-1
   PubMedGoogle Scholar
• Hedl M, Abraham C. Negative regulation of human mononuclear phagocyte function. Mucosal Immunol. 2013;6(2):205–223.
   PubMedGoogle Scholar
• Celada A, Borràs FE, Soler C, et al. The transcription factor PU. 1 is involved in macrophage proliferation. J Exp Med. 1996;184(1):61–69. doi:10.1084/jem.184.1.61
   PubMedGoogle Scholar
• Ma X, Lin WY, Chen Y, et al. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure. 2012;20(4):676–687. doi:10.1016/j.str.2012.02.010
   PubMed Web of Science ®Google Scholar
• Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56(6):947–958. doi:10.1182/blood.V56.6.947.947
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock H. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today. 1996;17(9):424–428. doi:10.1016/0167-5699(96)10029-3
   PubMedGoogle Scholar
• Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82. doi:10.1016/S1074-7613(03)00174-2
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74–e80. doi:10.1182/blood-2010-02-258558
   PubMed Web of Science ®Google Scholar
• Cros J, Cagnard N, Woollard K, et al. Human CD14 dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010;33(3):375–386. doi:10.1016/j.immuni.2010.08.012
   PubMed Web of Science ®Google Scholar
• Wong KL, Tai JJ-Y, Wong W-C, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118(5):e16–e31. doi:10.1182/blood-2010-12-326355
   PubMed Web of Science ®Google Scholar
• Rogacev KS, Ulrich C, Blömer L, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J. 2010;31(3):369–376. doi:10.1093/eurheartj/ehp308
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830. doi:10.1172/JCI200319451
   PubMed Web of Science ®Google Scholar
• Bories G, Caiazzo R, Derudas B, et al. Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Diabetes Vasc Dis Res. 2012;9(3):189–195. doi:10.1177/1479164111430242
   PubMedGoogle Scholar
• Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol. 2014;5:470. doi:10.3389/fimmu.2014.00470
   PubMed Web of Science ®Google Scholar
• Jung UJ, Seo YR, Ryu R, Choi M-S. Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects. Br J Nutr. 2016;116(6):1022–1032. doi:10.1017/S0007114516002993
   PubMedGoogle Scholar
• Kullo IJ, Hensrud DD, Allison TG. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, ≥30). Am J Cardiol. 2002;89(12):1441–1443. doi:10.1016/s0002-9149(02)02366-4
   PubMedGoogle Scholar
• Babio N, Ibarrola-Jurado N, Bulló M, et al. White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. PLoS One. 2013;8(3):e58354. doi:10.1371/journal.pone.0058354
   PubMed Web of Science ®Google Scholar
• Viardot A, Heilbronn L, Samocha‐Bonet D, Mackay F, Campbell L, Samaras K. Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev. 2012;28(5):447–454. doi:10.1002/dmrr.2302
   PubMed Web of Science ®Google Scholar
• Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18(6):228–232. doi:10.1016/j.tcm.2008.11.004
   PubMed Web of Science ®Google Scholar
• Jialal I, Adams-Huet B, Devaraj S. Monocyte cell adhesion molecule receptors in nascent metabolic syndrome. Clin Biochem. 2016;49(6):505–507. doi:10.1016/j.clinbiochem.2015.12.009
   PubMedGoogle Scholar
• Tanaka SI, Isoda F, Ishihara Y, Kimura M, Yamakawa T. T lymphopaenia in relation to body mass index and TNF‐α in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf). 2001;54(3):347–354.
   PubMed Web of Science ®Google Scholar
• Satoh N, Shimatsu A, Himeno A, et al. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients. Diabetes Care. 2010;33(1):e7–e7. doi:10.2337/dc09-1315
   PubMedGoogle Scholar
• Garton T, Keep RF, Hua Y, Xi G. CD163, a hemoglobin/haptoglobin scavenger receptor, after intracerebral hemorrhage: functions in microglia/macrophages versus neurons. Transl Stroke Res. 2017;8(6):612–616.
   PubMedGoogle Scholar
• Kim JE, Lin G, Zhou J, Mund JA, Case J, Campbell WW. Weight loss achieved using an energy restriction diet with normal or higher dietary protein decreased the number of CD14++ CD16+ proinflammatory monocytes and plasma lipids and lipoproteins in middle-aged, overweight, and obese adults. Nutr Res. 2017;40:75–84. doi:10.1016/j.nutres.2017.02.007
   PubMedGoogle Scholar
• Wonner R, Wallner S, Orsó E, Schmitz G. Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry Part B. 2018;94(4):596–605. doi:10.1002/cyto.b.v94.4
   PubMedGoogle Scholar
• Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762. doi:10.1038/nature01705
   PubMed Web of Science ®Google Scholar
• Ghadge AA, Khaire AA, Kuvalekar AA. Adiponectin: a potential therapeutic target for metabolic syndrome. Cytokine Growth Factor Rev. 2018;39:151–158. doi:10.1016/j.cytogfr.2018.01.004
   PubMed Web of Science ®Google Scholar
• Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 2005;45(5):828–833. doi:10.1161/01.HYP.0000163475.04421.e4
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103(8):1057–1063. doi:10.1161/01.CIR.103.8.1057
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96(5):1723–1732. doi:10.1182/blood.V96.5.1723
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Folco EJ, Minami M, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2008;102(2):218–225. doi:10.1161/CIRCRESAHA.107.164988
   PubMedGoogle Scholar
• Poglio S, De Toni F, Lewandowski D, et al. In situ production of innate immune cells in murine white adipose tissue. Blood. 2012;120(25):4952–4962
   PubMedGoogle Scholar
• Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014;157(4):832–844. doi:10.1016/j.cell.2014.04.016
   PubMed Web of Science ®Google Scholar
• Cousin B, Munoz O, André M, et al. A role for preadipocytes as macrophage-like cells. FASEB J. 1999;13(2):305–312. doi:10.1096/fsb2.v13.2
   PubMed Web of Science ®Google Scholar
• Charrière G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophages: evidence of plasticity. J Biol Chem. 2003;278(11):9850–9855. doi:10.1074/jbc.M210811200
   PubMed Web of Science ®Google Scholar
• Hill AA, Anderson-Baucum EK, Kennedy AJ, Webb CD, Yull FE, Hasty AH. Activation of NF-κB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment. Mol Metab. 2015;4(10):665–677. doi:10.1016/j.molmet.2015.07.005
   PubMedGoogle Scholar
• Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10(4):432. doi:10.3390/nu10040432
   PubMed Web of Science ®Google Scholar
• De Angulo A, Travis P, Jolly C. Obesity-Induced T Cell Senescence Contributes to Prostate Cancer Progression. AACR; 2018.
   Google Scholar
• Filgueiras LR, Serezani CH, Jancar S. Leukotriene B4 as a potential therapeutic target for the treatment of metabolic disorders. Front Immunol. 2015;6. doi:10.3389/fimmu.2015.00515
   PubMedGoogle Scholar
• Chung J, Nguyen A-K, Henstridge DC, et al. HSP72 protects against obesity-induced insulin resistance. Proc National Acad Sci. 2008;105(5):1739–1744. doi:10.1073/pnas.0705799105
   PubMed Web of Science ®Google Scholar
• Kurucz I, Morva A, Vaag A, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes. 2002;51(4):1102–1109. doi:10.2337/diabetes.51.4.1102
   PubMed Web of Science ®Google Scholar
• Ringseis R, Eder K, Mooren F, Krüger K. Metabolic signals and innate immune activation in obesity and exercise. inflammation. 2015;10(14):157–167.
   Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820. doi:10.1016/j.cell.2010.01.022
   PubMed Web of Science ®Google Scholar
• Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G, Bhatta R. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol. 2018;37(1):20–36. doi:10.1080/08830185.2017.1380200
   PubMed Web of Science ®Google Scholar
• Goulopoulou S, McCarthy CG, Webb RC. Toll-like receptors in the vascular system: sensing the dangers within. Pharmacol Rev. 2016;68(1):142–167. doi:10.1124/pr.114.010090
   PubMed Web of Science ®Google Scholar
• Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science. 2010;327(5963):296–300. doi:10.1126/science.1184003
   PubMed Web of Science ®Google Scholar
• Jo E-K, Kim JK, Shin D-M, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148–1459.
   PubMed Web of Science ®Google Scholar
• Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2013;99(1):39–48. doi:10.1210/jc.2013-3092
   PubMedGoogle Scholar
• Salehian B, Mahabadi V. The crossroad of inflammation and diabetes: role of toll-like receptor. Int J Diabetes Clin Res. 2015;2(3). doi:10.23937/2377-3634/1410032
   Google Scholar
• Rada I, Deldicque L, Francaux M, Zbinden-Foncea H. Toll like receptor expression induced by exercise in obesity and metabolic syndrome: a systematic review. Exerc Immunol Rev. 2018;24.
   PubMedGoogle Scholar
• Zhang X-J, Zhang P, Li H. Interferon regulatory factor signalings in cardiometabolic diseases. Hypertension. 2015;66(2):222–247. doi:10.1161/HYPERTENSIONAHA.115.04898
   PubMedGoogle Scholar
• Farrugia M, Baron B. The role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism. Int J Inflam. 2017;2017.
   PubMedGoogle Scholar
• Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol. 2012;3:138. doi:10.3389/fphys.2012.00138
   PubMedGoogle Scholar
• Kim S-J, Choi Y, Choi Y-H, Park T. Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem. 2012;23(2):113–122. doi:10.1016/j.jnutbio.2010.10.012
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511. doi:10.1038/nri1391
   PubMed Web of Science ®Google Scholar
• Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 1997;7(6):837–847. doi:10.1016/S1074-7613(00)80402-1
   PubMed Web of Science ®Google Scholar
• Medvedev AE, Lentschat A, Kuhns DB, et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med. 2003;198(4):521–531. doi:10.1084/jem.20030701
   PubMedGoogle Scholar
• Kondo T, Kawai T, Akira S. Dissecting negative regulation of toll-like receptor signaling. Trends Immunol. 2012;33(9):449–458. doi:10.1016/j.it.2012.05.002
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol. 2007;7(5):353–364. doi:10.1038/nri2079
   PubMed Web of Science ®Google Scholar
• Orr JS, Puglisi MJ, Ellacott KL, Lumeng CN, Wasserman DH, Hasty AH. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes. 2012;61(11):2718–2727.
   PubMed Web of Science ®Google Scholar
• Lancaster GI, Febbraio MA. The immunomodulating role of exercise in metabolic disease. Trends Immunol. 2014;35(6):262–269. doi:10.1016/j.it.2014.02.008
   PubMed Web of Science ®Google Scholar
• Naghizadeh M, Baradaran B, Saghafi-Asl M, et al. Toll-like receptor signaling and serum levels of interferon β and lipopolysaccharide binding protein are related to abdominal obesity: a case-control study between metabolically healthy and metabolically unhealthy obese individuals. Nutr Res. 2018;55:11–20. doi:10.1016/j.nutres.2018.03.014
   PubMedGoogle Scholar
• Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid–induced insulin resistance. J Clin Invest. 2006;116(11):3015–3025. doi:10.1172/JCI28898
   PubMed Web of Science ®Google Scholar
• Youssef-Elabd EM, McGee KC, Tripathi G, et al. Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. J Nutr Biochem. 2012;23(1):39–50. doi:10.1016/j.jnutbio.2010.11.003
   PubMedGoogle Scholar
• Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35(4):900–904. doi:10.2337/dc11-2375
   PubMed Web of Science ®Google Scholar
• Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4–dependent and–independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 2005;25(6):1213–1219. doi:10.1161/01.ATV.0000159891.73193.31
   PubMed Web of Science ®Google Scholar
• Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292(3):E740–E747. doi:10.1152/ajpendo.00302.2006
   PubMed Web of Science ®Google Scholar
• Caricilli AM, Nascimento PH, Pauli JR, et al. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol. 2008;199(3):399–406. doi:10.1677/JOE-08-0354
   PubMedGoogle Scholar
• Ahmad R, Al-Mass A, Atizado V, et al. Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. Journal of inflammation. 2012;9(1):48.
   Google Scholar
• Reyna SM, Ghosh S, Tantiwong P, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes. 2008;57(10):2595-2602.
   PubMed Web of Science ®Google Scholar
• Arias-Loste MT, Iruzubieta P, Puente Á, et al. Increased expression profile and functionality of TLR6 in peripheral blood mononuclear cells and hepatocytes of morbidly obese patients with non-alcoholic fatty liver disease. International journal of molecular sciences. 2016;17(11):1878.
   PubMedGoogle Scholar
• Ahmad R, Shihab PK, Thomas R, et al. Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity. Diabetology & metabolic syndrome. 2015;7(1):71.
   PubMedGoogle Scholar
• Gupta S, Maratha A, Siednienko J, et al. Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications. Scientific reports. 2017;7(1):7633.
   PubMedGoogle Scholar
• Thomas RS, Kochumon S, Sindhu S, Ahmad R. Elevated expression of TLR10 in the adipose tissue in obesity: Implication in metabolic inflammation. In: Am Assoc Immnol; 2017.
   Google Scholar
• Cuevas AM, Lazo M, Zuñiga I, et al. Expression of MYD88 in Adipose Tissue of Obese People: Is There Some Role in the Development of Metabolic Syndrome? Metabolic syndrome and related disorders. 2017;15(2):80-85.
   PubMedGoogle Scholar
• Amiri P, Naghizadeh M, Baradaran B, Saghafi-Asl M, Shanehbandi D, Mirmajidi S. Insulin resistance in relation to inflammatory gene expression and metabolic features in apparently healthy obese individuals. International Journal of Diabetes in Developing Countries. 2018:1-8.
   PubMedGoogle Scholar
• da Silva Correia J, Ulevitch RJ. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem. 2002;277(3):1845–1854.
   PubMedGoogle Scholar
• Pan Z, Zhou L, Hetherington CJ, Zhang D-E. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. J Biol Chem. 2000;275(46):36430–36435. doi:10.1074/jbc.M003192200
   PubMedGoogle Scholar
• Pugin JM, Schürer-Maly C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc National Acad Sci. 1993;90(7):2744–2748. doi:10.1073/pnas.90.7.2744
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM. Pérez del Pulgar S, Luche E, et al., CD14 modulates inflammation-driven insulin resistance. Diabetes. 2011;60(8):2179–2186. doi:10.2337/db10-1210
   PubMedGoogle Scholar
• Ogawa Y, Imajo K, Yoneda M, et al. Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis. PLoS One. 2013;8(6):e65211. doi:10.1371/journal.pone.0065211
   PubMed Web of Science ®Google Scholar
• Jialal I, Rajamani U, Adams-Huet B, Kaur H. Circulating pathogen associated molecular pattern–binding proteins and high mobility group box protein 1 in nascent metabolic syndrome: implications for cellular toll-like receptor activity. Atherosclerosis. 2014;236(1):182–187. doi:10.1016/j.atherosclerosis.2014.06.022
   PubMedGoogle Scholar
• Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointestinal Liver Physiol. 2011;300(3):G433–G441. doi:10.1152/ajpgi.00163.2009
   PubMed Web of Science ®Google Scholar
• Liew FY, Xu D, Brint EK, O’Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005;5(6):446–458. doi:10.1038/nri1630
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Pottle J, Ni M, He Y, Zhang ZY, Buckner JH. Negative regulation of TLR signaling in myeloid cells—implications for autoimmune diseases. Immunol Rev. 2016;269(1):212–227. doi:10.1111/imr.12381
   PubMedGoogle Scholar
• Negishi H, Ohba Y, Yanai H, et al. Negative regulation of toll-like-receptor signaling by IRF-4. Proc National Acad Sci. 2005;102(44):15989–15994. doi:10.1073/pnas.0508327102
   PubMedGoogle Scholar
• Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF–dependent toll-like receptor signaling. Nat Immunol. 2006;7(10):1074. doi:10.1038/ni1382
   PubMed Web of Science ®Google Scholar
• Takezako N, Hayakawa M, Hayakawa H, et al. ST2 suppresses IL-6 production via the inhibition of IκB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun. 2006;341(2):425–432. doi:10.1016/j.bbrc.2005.12.206
   PubMedGoogle Scholar
• Zhou F, Zhang X, van Dam H, Ten Dijke P, Huang H, Zhang L. Ubiquitin-specific protease 4 mitigates toll-like/interleukin-1 receptor signaling and regulates innate immune activation. J Biol Chem. 2012;287(14):11002–11010. doi:10.1074/jbc.M111.328187
   PubMedGoogle Scholar
• Enesa K, Moll HP, Luong L, Ferran C, Evans PC. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes. FASEB J. 2015;29(5):1869–1878. doi:10.1096/fsb2.v29.5
   PubMedGoogle Scholar
• Skaug B, Chen J, Du F, He J, Ma A, Chen ZJ. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell. 2011;44(4):559–571. doi:10.1016/j.molcel.2011.09.015
   PubMed Web of Science ®Google Scholar
• Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of toll-like receptor responses. Nat Immunol. 2004;5(10):1052–1060. doi:10.1038/ni1110
   PubMed Web of Science ®Google Scholar
• Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143.
   PubMed Web of Science ®Google Scholar
• Brunelli DT, Chacon-Mikahil M, Gáspari AF, et al. Combined training reduces subclinical inflammation in obese middle-age men. Med Sci Sports Exerc. 2015;47(10):2207–2215. doi:10.1249/MSS.0000000000000658
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Church TS, Milani RV, Earnest CP. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. 2011;31(3):137–145. doi:10.1097/HCR.0b013e3182122827
   PubMed Web of Science ®Google Scholar
• You T, Arsenis NC, Disanzo BL, LaMonte MJ. Effects of exercise training on chronic inflammation in obesity. Sports Med. 2013;43(4):243–256. doi:10.1007/s40279-013-0023-3
   PubMedGoogle Scholar
• Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607. doi:10.1038/nri3041
   PubMed Web of Science ®Google Scholar
• Goh J, Goh KP, Abbasi A. Exercise and adipose tissue macrophages: new frontiers in obesity research? Front Endocrinol (Lausanne). 2016;7. doi:10.3389/fendo.2016.00065
   PubMedGoogle Scholar
• Kawanishi N, Yano H, Yokogawa Y, Suzuki K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev. 2010;16.
   PubMedGoogle Scholar
• Oliveira AG, Araujo TG, Carvalho BM, et al. Acute exercise induces a phenotypic switch in adipose tissue macrophage polarization in diet‐induced obese rats. Obesity. 2013;21(12):2545–2556. doi:10.1002/oby.20402
   PubMedGoogle Scholar
• Xiong X-Q, Geng Z, Zhou B, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31–41. doi:10.1016/j.metabol.2018.01.013
   PubMed Web of Science ®Google Scholar
• Ruffino J, Davies N, Morris K, et al. Moderate-intensity exercise alters markers of alternative activation in circulating monocytes in females: a putative role for PPARγ. Eur J Appl Physiol. 2016;116(9):1671–1682. doi:10.1007/s00421-016-3414-y
   PubMedGoogle Scholar
• Colato A, Abreu F, Medeiros N, et al. Effects of concurrent training on inflammatory markers and expression of CD4, CD8, and HLA-DR in overweight and obese adults. J Exercise Sci Fitness. 2014;12(2):55–61. doi:10.1016/j.jesf.2014.06.002
   Google Scholar
• Barry JC, Simtchouk S, Durrer C, Jung ME, Little JP. Short-term exercise training alters leukocyte chemokine receptors in obese adults. Med Sci Sports Exerc. 2017;49(8):1631–1640. doi:10.1249/MSS.0000000000001261
   PubMed Web of Science ®Google Scholar
• Matos MA, Duarte TC, Ottone V, et al. The effect of insulin resistance and exercise on the percentage of CD16+ monocyte subset in obese individuals. Cell Biochem Funct. 2016;34(4):209–216. doi:10.1002/cbf.3178
   PubMedGoogle Scholar
• Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab. 2006;290(5):E961–E967. doi:10.1152/ajpendo.00506.2005
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu S-X, Cai Y, Xie K-L, Zhang W-L, Zheng F. Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2 diabetes mellitus. J Phys Ther Sci. 2015;27(7):2365–2371. doi:10.1589/jpts.27.2365
   PubMedGoogle Scholar
• Leggate M, Carter WG, Evans MJ, Vennard RA, Sribala-Sundaram S, Nimmo MA. Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J Appl Physiol. 2012;112(8):1353–1360. doi:10.1152/japplphysiol.01080.2011
   PubMed Web of Science ®Google Scholar
• Haczeyni F, Barn V, Mridha AR, et al. Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. Obesity. 2015;23(9):1845–1855. doi:10.1002/oby.21170
   PubMedGoogle Scholar
• Dorneles GP, Haddad DO, Fagundes VO, et al. High intensity interval exercise decreases IL-8 and enhances the immunomodulatory cytokine interleukin-10 in lean and overweight–obese individuals. Cytokine. 2016;77:1–9. doi:10.1016/j.cyto.2015.10.003
   PubMed Web of Science ®Google Scholar
• Oliveira AG, Carvalho BM, Tobar N, et al. Physical exercise reduces circulating lipopolysaccharide and toll–like receptor 4 activation and improves insulin signaling in tissues of diet-induced obesity rats. Diabetes. 2011;60(3):784–796.
   PubMedGoogle Scholar
• Vieira VJ, Valentine RJ, Wilund KR, Antao N, Baynard T, Woods JA. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am J Physiol Endocrinol Metab. 2009;296(5):E1164–E1171. doi:10.1152/ajpendo.00054.2009
   PubMedGoogle Scholar
• Khadir A, Kavalakatt S, Cherian P, et al. Physical exercise enhanced heat shock protein 60 expression and attenuated inflammation in the adipose tissue of human diabetic obese. Front Endocrinol (Lausanne). 2018;9:16. doi:10.3389/fendo.2018.00016
   PubMedGoogle Scholar
• Rodriguez-Miguelez P, Fernandez-Gonzalo R, Collado PS, et al. Whole-body vibration improves the anti-inflammatory status in elderly subjects through toll-like receptor 2 and 4 signaling pathways. Mech Ageing Dev. 2015;150:12–19. doi:10.1016/j.mad.2015.08.002
   PubMed Web of Science ®Google Scholar
• Auerbach P, Nordby P, Bendtsen LQ, et al. Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men. Am J Physiol Regul Integr Comp Physiol. 2013;305(5):R490–R498. doi:10.1152/ajpregu.00575.2012
   PubMedGoogle Scholar
• Reyna SM, Tantiwong P, Cersosimo E, DeFronzo RA, Sriwijitkamol A, Musi N. Short-term exercise training improves insulin sensitivity but does not inhibit inflammatory pathways in immune cells from insulin-resistant subjects. J Diabetes Res. 2013;2013.
   PubMedGoogle Scholar
• Durrer C, Francois M, Neudorf H, Little JP. Acute high-intensity interval exercise reduces human monocyte Toll-like receptor 2 expression in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol. 2017;312(4):R529–R538. doi:10.1152/ajpregu.00348.2016
   PubMed Web of Science ®Google Scholar
• Dorneles GP, da Silva IRV, Korb A, et al. High intensity interval exercise enhances the global HDAC activity in PBMC and anti-inflammatory cytokines of overweight-obese subjects. Obesity Med. 2016;2:25–30. doi:10.1016/j.obmed.2016.05.004
   Google Scholar
• de Souza DC, Matos VA. dos Santos VO, et al,. Effects of high-intensity interval and moderate-intensity continuous exercise on inflammatory, leptin, IgA, and lipid peroxidation responses in obese males. Front Physiol. 2018;9. doi:10.3389/fphys.2018.00567
   Google Scholar
• Barry JC, Simtchouk S, Durrer C, Jung ME, Mui AL, Little JP. Short-term exercise training reduces anti-inflammatory action of interleukin-10 in adults with obesity. Cytokine. 2018;111:460–469. doi:10.1016/j.cyto.2018.05.035
   PubMedGoogle Scholar
• Robinson E, Durrer C, Simtchouk S, et al. Short-term high-intensity interval and moderate-intensity continuous training reduce leukocyte TLR4 in inactive adults at elevated risk of type 2 diabetes. J Appl Physiol. 2015;119(5):508–516. doi:10.1152/japplphysiol.00334.2015
   PubMed Web of Science ®Google Scholar
• Yang HS, Woo JE, Lee SJ, Park SH, Woo JM. Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci. 2014;55(9):5989–5997. doi:10.1167/iovs.14-14864
   PubMedGoogle Scholar
• Rathcke C, Johansen J, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflammation Res. 2006;55(2):53–59. doi:10.1007/s00011-005-0010-8
   PubMed Web of Science ®Google Scholar
• Colato A, Fraga L, Dorneles G, Vianna P, Chies J, Peres A. Impact of aerobic water running training on peripheral immune-endocrine markers of overweight-obese women. Sci Sports. 2017;32(1):46–53. doi:10.1016/j.scispo.2016.04.003
   Google Scholar
• Nielsen AR, Hojman P, Erikstrup C, et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93(11):4486–4493. doi:10.1210/jc.2007-2561
   PubMed Web of Science ®Google Scholar
• Park S-M, Kwak Y-S, Ji J-G. The effects of combined exercise on health-related fitness, endotoxin, and immune function of postmenopausal women with abdominal obesity. J Immunol Res. 2015;2015.
   Google Scholar
• Chagas EFB, Bonfim MR, Turi BC, Brondino NCM, Monteiro HL. Effect of moderate intensity exercise on inflammatory markers among postmenopausal women. J Phys Act Health. 2017;14(6):479–485.
   PubMedGoogle Scholar
• Nunes PRP, Barcelos LC, Oliveira AA, et al. Effect of resistance training on muscular strength and indicators of abdominal adiposity, metabolic risk, and inflammation in postmenopausal women: controlled and randomized clinical trial of efficacy of training volume. Age. 2016;38(2):40. doi:10.1007/s11357-016-9901-6
   PubMedGoogle Scholar
• Orsatti FL, Nahas E, Maesta N, et al. Effects of resistance training frequency on body composition and metabolics and inflammatory markers in overweight postmenopausal women. J Sports Med Phys Fitness. 2014;54(3):317–325.
   PubMedGoogle Scholar
• Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153(3):242–250. doi:10.1093/aje/153.3.242
   PubMedGoogle Scholar
• Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure‐time physical activity and reduced plasma levels of obesity‐related inflammatory markers. Obes Res. 2003;11(9):1055–1064. doi:10.1038/oby.2003.145
   PubMedGoogle Scholar
• Otvos JD, Shalaurova I, Wolak-Dinsmore J, et al. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015;61(5):714–723. doi:10.1373/clinchem.2014.232918
   PubMed Web of Science ®Google Scholar
• Dungan K, Binkley P, Osei K. GlycA is a novel marker of inflammation among non-critically ill hospitalized patients with type 2 diabetes. Inflammation. 2015;38(3):1357–1363. doi:10.1007/s10753-014-0107-8
   PubMedGoogle Scholar
• Bartlett DB, Shepherd SO, Wilson OJ, et al. Neutrophil and monocyte bactericidal responses to 10 weeks of low-volume high-intensity interval or moderate-intensity continuous training in sedentary adults. Oxid Med Cell Longev. 2017;2017:1–12. doi:10.1155/2017/8148742
   Google Scholar
• Abbasi A, de Paula Vieira R, Bischof F, et al. Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise. J Neuroinflammation. 2016;13(1):289. doi:10.1186/s12974-016-0758-5
   PubMedGoogle Scholar
• Neves PRDS, Tenório TRDS, Lins TA, et al. Acute effects of high-and low-intensity exercise bouts on leukocyte counts. J Exercise Sci Fitness. 2015;13(1):24–28. doi:10.1016/j.jesf.2014.11.003
   PubMed Web of Science ®Google Scholar
• Child M, Leggate M, Gleeson M. Effects of two weeks of high-intensity interval training (HIIT) on monocyte TLR2 and TLR4 expression in high BMI sedentary men. Int J Exerc Sci. 2013;6(1):10.
   Google Scholar
• Shimizu K, Suzuki N, Imai T, et al. Monocyte and T-cell responses to exercise training in elderly subjects. J Strength Conditioning Res. 2011;25(9):2565–2572. doi:10.1519/JSC.0b013e3181fc5e67
   PubMedGoogle Scholar
• Folco EJ, Rocha VZ, López-Ilasaca M, Libby P. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284(38):25569–25575. doi:10.1074/jbc.M109.019786
   PubMed Web of Science ®Google Scholar
• Kim D-Y, Jung S-Y, Seo B-D. Effect of exercise intervention on changes in free fatty acid levels and metabolic risk factors in stroke patients. J Phys Ther Sci. 2014;26(2):275–279. doi:10.1589/jpts.26.275
   PubMedGoogle Scholar